Ardent Health, Inc. (ARDT) stock
ARDTNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/303% below fair value
$17.75−0.35 (-1.93%)
Close on Nov 17, 2026Market cap $2.50BP/E 32.3Yield –
Ardent Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Ardent Health's price to sales ratio was 0.4× on Nov 11, 2026, against 0.2× a year earlier. Over the last 2 years it ranged from 0.2× to 1.7×, with a median of 0.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | +0.2 |
| 2025 | Dec 31, 2025 | 0.2× | −1.3 |
| 2024 | Oct 31, 2024 | 1.5× | – |
See a number that looks wrong?